BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pich D, Mrozek-Gorska P, Bouvet M, Sugimoto A, Akidil E, Grundhoff A, Hamperl S, Ling PD, Hammerschmidt W. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. mBio 2019;10:e01723-19. [PMID: 31530670 DOI: 10.1128/mBio.01723-19] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Manara F, Jay A, Odongo GA, Mure F, Maroui MA, Diederichs A, Sirand C, Cuenin C, Granai M, Mundo L, Hernandez-Vargas H, Lazzi S, Khoueiry R, Gruffat H, Herceg Z, Accardi R. Epigenetic Alteration of the Cancer-Related Gene TGFBI in B Cells Infected with Epstein-Barr Virus and Exposed to Aflatoxin B1: Potential Role in Burkitt Lymphoma Development. Cancers (Basel) 2022;14:1284. [PMID: 35267594 DOI: 10.3390/cancers14051284] [Reference Citation Analysis]
2 Münz C. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses. Front Cell Infect Microbiol 2021;11:605258. [PMID: 33842383 DOI: 10.3389/fcimb.2021.605258] [Reference Citation Analysis]
3 Su C, Lu F, Soldan SS, Lamontagne RJ, Tang HY, Napoletani G, Farrell PJ, Tempera I, Kossenkov AV, Lieberman PM. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes. PLoS Pathog 2021;17:e1009834. [PMID: 34352044 DOI: 10.1371/journal.ppat.1009834] [Reference Citation Analysis]
4 Ohashi M, Hayes M, McChesney K, Johannsen E. Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes. PLoS Pathog 2021;17:e1009419. [PMID: 33720992 DOI: 10.1371/journal.ppat.1009419] [Reference Citation Analysis]
5 Serquiña AKP, Tagawa T, Oh D, Mahesh G, Ziegelbauer JM. 25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses. mBio 2021;:e0290721. [PMID: 34781692 DOI: 10.1128/mBio.02907-21] [Reference Citation Analysis]
6 Wallaschek N, Reuter S, Silkenat S, Wolf K, Niklas C, Kayisoglu Ö, Aguilar C, Wiegering A, Germer CT, Kircher S, Rosenwald A, Shannon-Lowe C, Bartfeld S. Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids. PLoS Pathog 2021;17:e1009210. [PMID: 33596248 DOI: 10.1371/journal.ppat.1009210] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Hong T, Parameswaran S, Donmez OA, Miller D, Forney C, Lape M, Saint Just Ribeiro M, Liang J, Edsall LE, Magnusen AF, Miller W, Chepelev I, Harley JB, Zhao B, Kottyan LC, Weirauch MT. Epstein-Barr virus nuclear antigen 2 extensively rewires the human chromatin landscape at autoimmune risk loci. Genome Res 2021. [PMID: 34799401 DOI: 10.1101/gr.264705.120] [Reference Citation Analysis]
8 Beer S, Wange LE, Zhang X, Kuklik-Roos C, Enard W, Hammerschmidt W, Scialdone A, Kempkes B. EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells. Proc Natl Acad Sci U S A 2022;119:e2200512119. [PMID: 35857872 DOI: 10.1073/pnas.2200512119] [Reference Citation Analysis]
9 Bernaudat F, Gustems M, Günther J, Oliva MF, Buschle A, Göbel C, Pagniez P, Lupo J, Signor L, Müller CW, Morand P, Sattler M, Hammerschmidt W, Petosa C. Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA/Zta/BZLF1. Nucleic Acids Res 2021:gkab1183. [PMID: 34893887 DOI: 10.1093/nar/gkab1183] [Reference Citation Analysis]
10 Albanese M, Chen YA, Hüls C, Gärtner K, Tagawa T, Mejias-Perez E, Keppler OT, Göbel C, Zeidler R, Shein M, Schütz AK, Hammerschmidt W. MicroRNAs are minor constituents of extracellular vesicles that are rarely delivered to target cells. PLoS Genet 2021;17:e1009951. [PMID: 34871319 DOI: 10.1371/journal.pgen.1009951] [Reference Citation Analysis]
11 Neuhaus J, Berndt-Paetz M, Gonsior A. Biomarkers in the Light of the Etiopathology of IC/BPS. Diagnostics (Basel) 2021;11:2231. [PMID: 34943467 DOI: 10.3390/diagnostics11122231] [Reference Citation Analysis]
12 Tsai K, Cullen BR. Epigenetic and epitranscriptomic regulation of viral replication. Nat Rev Microbiol 2020;18:559-70. [PMID: 32533130 DOI: 10.1038/s41579-020-0382-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
13 Yang T, You C, Meng S, Lai Z, Ai W, Zhang J. EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis. Front Cell Infect Microbiol 2022;12:935205. [DOI: 10.3389/fcimb.2022.935205] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lamontagne RJ, Soldan SS, Su C, Wiedmer A, Won KJ, Lu F, Goldman AR, Wickramasinghe J, Tang HY, Speicher DW, Showe L, Kossenkov AV, Lieberman PM. A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism. PLoS Pathog 2021;17:e1009208. [PMID: 33497421 DOI: 10.1371/journal.ppat.1009208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Münz C. Redirecting T Cells against Epstein-Barr Virus Infection and Associated Oncogenesis. Cells 2020;9:E1400. [PMID: 32512847 DOI: 10.3390/cells9061400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
16 Guo R, Gewurz BE. Epigenetic control of the Epstein-Barr lifecycle. Curr Opin Virol 2021;52:78-88. [PMID: 34891084 DOI: 10.1016/j.coviro.2021.11.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Sugimoto A. Replication Compartments-The Great Survival Strategy for Epstein-Barr Virus Lytic Replication. Microorganisms 2022;10:896. [PMID: 35630341 DOI: 10.3390/microorganisms10050896] [Reference Citation Analysis]
18 Buschle A, Mrozek-Gorska P, Cernilogar FM, Ettinger A, Pich D, Krebs S, Mocanu B, Blum H, Schotta G, Straub T, Hammerschmidt W. Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation. Nucleic Acids Res 2021;49:3217-41. [PMID: 33675667 DOI: 10.1093/nar/gkab099] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Deng Y, Münz C. Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein-Barr Virus. Cancers (Basel) 2021;13:2275. [PMID: 34068598 DOI: 10.3390/cancers13092275] [Reference Citation Analysis]
20 Deng Y, Chatterjee B, Zens K, Zdimerova H, Müller A, Schuhmachers P, Ligeon LA, Bongiovanni A, Capaul R, Zbinden A, Holler A, Stauss H, Hammerschmidt W, Münz C. CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion. Blood 2021;137:3225-36. [PMID: 33827115 DOI: 10.1182/blood.2020009482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Inagaki T, Sato Y, Ito J, Takaki M, Okuno Y, Yaguchi M, Masud HMAA, Watanabe T, Sato K, Iwami S, Murata T, Kimura H. Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection. Front Microbiol 2020;11:575255. [PMID: 33613459 DOI: 10.3389/fmicb.2020.575255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bouvet M, Voigt S, Tagawa T, Albanese M, Chen YA, Chen Y, Fachko DN, Pich D, Göbel C, Skalsky RL, Hammerschmidt W. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus. mBio 2021;12:e03440-20. [PMID: 33785626 DOI: 10.1128/mBio.03440-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Münz C. Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses. Viruses 2021;13:859. [PMID: 34066671 DOI: 10.3390/v13050859] [Reference Citation Analysis]
24 Akidil E, Albanese M, Buschle A, Ruhle A, Pich D, Keppler OT, Hammerschmidt W. Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection. PLoS Pathog 2021;17:e1009117. [PMID: 33857265 DOI: 10.1371/journal.ppat.1009117] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Westhoff Smith D, Chakravorty A, Hayes M, Hammerschmidt W, Sugden B. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells. mBio 2021;:e0224321. [PMID: 34781735 DOI: 10.1128/mBio.02243-21] [Reference Citation Analysis]
26 Burton EM, Voyer J, Gewurz BE. Epstein-Barr virus latency programs dynamically sensitize B cells to ferroptosis. Proc Natl Acad Sci U S A 2022;119:e2118300119. [PMID: 35275790 DOI: 10.1073/pnas.2118300119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Tempera I, Lieberman PM. Oncogenic Viruses as Entropic Drivers of Cancer Evolution. Front Virol 2021;1:753366. [PMID: 35141704 DOI: 10.3389/fviro.2021.753366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Guo R, Jiang C, Zhang Y, Govande A, Trudeau SJ, Chen F, Fry CJ, Puri R, Wolinsky E, Schineller M, Frost TC, Gebre M, Zhao B, Giulino-Roth L, Doench JG, Teng M, Gewurz BE. MYC Controls the Epstein-Barr Virus Lytic Switch. Mol Cell 2020;78:653-669.e8. [PMID: 32315601 DOI: 10.1016/j.molcel.2020.03.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
29 Zhang Y, Jiang C, Trudeau SJ, Narita Y, Zhao B, Teng M, Guo R, Gewurz BE. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation. mBio 2020;11:e01063-20. [PMID: 33109754 DOI: 10.1128/mBio.01063-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
30 Manet E, Polvèche H, Mure F, Mrozek-Gorska P, Roisné-Hamelin F, Hammerschmidt W, Auboeuf D, Gruffat H. Modulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein. Nucleic Acids Res 2021;49:10657-76. [PMID: 34530456 DOI: 10.1093/nar/gkab787] [Reference Citation Analysis]
31 Münz C. The Role of Dendritic Cells in Immune Control and Vaccination against -Herpesviruses. Viruses 2019;11:E1125. [PMID: 31817510 DOI: 10.3390/v11121125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
32 Zelazowska MA, McBride K, Krug LT. Dangerous Liaisons: Gammaherpesvirus Subversion of the Immunoglobulin Repertoire. Viruses 2020;12:E788. [PMID: 32717815 DOI: 10.3390/v12080788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Gonsior A, Neuhaus J. [Interstitial cystitis: the latest findings on its aetiopathogenesis]. Aktuelle Urol 2021;52:539-46. [PMID: 34847607 DOI: 10.1055/a-1652-1162] [Reference Citation Analysis]
34 Yiu SPT, Guo R, Zerbe C, Weekes MP, Gewurz BE. Epstein-Barr virus BNRF1 destabilizes SMC5/6 cohesin complexes to evade its restriction of replication compartments. Cell Rep 2022;38:110411. [PMID: 35263599 DOI: 10.1016/j.celrep.2022.110411] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Rosemarie Q, Sugden B. Epstein-Barr Virus: How Its Lytic Phase Contributes to Oncogenesis. Microorganisms 2020;8:E1824. [PMID: 33228078 DOI: 10.3390/microorganisms8111824] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]